Transcription factor HNF4 & alpha;2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy

Carregando...
Imagem de Miniatura
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC CLINICAL INVESTIGATION INC
Autores
MARTINEZ-CALLE, Marta
COURBON, Guillaume
HUNT-TOBEY, Bridget
FRANCIS, Connor
SPINDLER, Jadeah
WANG, Xueyan
SALUSKY, Isidro B.
MALLUCHE, Hartmut
Citação
JOURNAL OF CLINICAL INVESTIGATION, v.133, n.11, article ID e159928, 18p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Renal osteodystrophy (ROD) is a disorder of bone metabolism that affects virtually all patients with chronic kidney disease (CKD) and is associated with adverse clinical outcomes including fractures, cardiovascular events, and death. In this study, we showed that hepatocyte nuclear factor 4 & alpha; (HNF4 & alpha;), a transcription factor mostly expressed in the liver, is also expressed in bone, and that osseous HNF4 & alpha; expression was dramatically reduced in patients and mice with ROD. Osteoblast-specific deletion of Hnf4 & alpha; resulted in impaired osteogenesis in cells and mice. Using multi-omics analyses of bones and cells lacking or overexpressing Hnf4 & alpha;1 and Hnf4 & alpha;2, we showed that HNF4 & alpha;2 is the main osseous Hnf4 & alpha; isoform that regulates osteogenesis, cell metabolism, and cell death. As a result, osteoblast-specific overexpression of Hnf4 & alpha;2 prevented bone loss in mice with CKD. Our results showed that HNF4 & alpha;2 is a transcriptional regulator of osteogenesis, implicated in the development of ROD.
Palavras-chave
Referências
  1. Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127
  2. Anuradha S, 2011, CLIN GENET, V80, P541, DOI 10.1111/j.1399-0004.2010.01577.x
  3. Behrendt AK, 2016, J BONE MINER RES, V31, P852, DOI 10.1002/jbmr.2745
  4. Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599
  5. Chahar S, 2014, MOL CELL BIOL, V34, P3291, DOI 10.1128/MCB.00349-14
  6. Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966
  7. CHARTIER FL, 1994, GENE, V147, P269, DOI 10.1016/0378-1119(94)90079-5
  8. Courbon G, 2021, BONE RES, V9, DOI 10.1038/s41413-021-00154-0
  9. Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609
  10. David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622
  11. David V, 2006, AM J PHYSIOL-ENDOC M, V290, pE440, DOI 10.1152/ajpendo.00293.2004
  12. David V, 2008, TISSUE ENG PT A, V14, P117, DOI 10.1089/ten.a.2007.0051
  13. David V, 2016, KIDNEY INT, V89, P135, DOI 10.1038/ki.2015.290
  14. David V, 2013, ENDOCRINOLOGY, V154, P4469, DOI 10.1210/en.2013-1627
  15. Dell H, 1999, J BIOL CHEM, V274, P9013, DOI 10.1074/jbc.274.13.9013
  16. Denburg M, 2018, AM J KIDNEY DIS, V71, P154, DOI 10.1053/j.ajkd.2017.10.007
  17. Denburg MR, 2016, J AM SOC NEPHROL, V27, P543, DOI 10.1681/ASN.2015020152
  18. Drewes T, 1996, MOL CELL BIOL, V16, P925
  19. Dussold C, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0051-1
  20. Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024
  21. Ferguson JF, 2013, J AM COLL CARDIOL, V62, P789, DOI 10.1016/j.jacc.2013.01.103
  22. Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
  23. Groothoff JW, 2003, KIDNEY INT, V63, P266, DOI 10.1046/j.1523-1755.2003.00727.x
  24. Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365
  25. Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742
  26. Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
  27. Hirao J, 2011, J TOXICOL SCI, V36, P9, DOI 10.2131/jts.36.9
  28. Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200
  29. HOLM S, 1979, SCAND J STAT, V6, P65
  30. Hoy F B, 1988, IMJ Ill Med J, V174, P141
  31. Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226
  32. Imig JD, 2013, COMPR PHYSIOL, V3, P957, DOI 10.1002/cphy.c120028
  33. Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47
  34. Jafar-Mohammadi B, 2011, DIABETOLOGIA, V54, P111, DOI 10.1007/s00125-010-1916-4
  35. Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5
  36. Kanazawa T, 2009, ANAT HISTOL EMBRYOL, V38, P34, DOI 10.1111/j.1439-0264.2008.00889.x
  37. Karasik D, 2012, J BONE MINER RES, V27, P319, DOI 10.1002/jbmr.563
  38. Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4
  39. Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419
  40. Kim SM, 2016, J BONE MINER RES, V31, P1803, DOI 10.1002/jbmr.2862
  41. Ko HL, 2019, CELL REP, V26, P2549, DOI 10.1016/j.celrep.2019.02.033
  42. Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921
  43. Lambert E, 2020, MOL CELL PROTEOMICS, V19, P808, DOI 10.1074/mcp.RA119.001909
  44. Laster M, 2021, J BONE MINER RES, V36, P298, DOI 10.1002/jbmr.4182
  45. Li ZH, 2015, BONE, V81, P468, DOI 10.1016/j.bone.2015.08.017
  46. Marable SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97497
  47. Marcil V, 2012, GENES IMMUN, V13, P556, DOI 10.1038/gene.2012.37
  48. Martin A, 2012, MOL ENDOCRINOL, V26, P1883, DOI 10.1210/me.2012-1062
  49. Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816
  50. Mazzaferro S, 2021, CALCIFIED TISSUE INT, V108, P452, DOI 10.1007/s00223-020-00794-0
  51. Mihai S, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2180373
  52. Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742
  53. Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159
  54. Neuburg S, 2018, NEPHROL DIAL TRANSPL, V33, P1129, DOI 10.1093/ndt/gfx332
  55. Nikolaidou-Neokosmidou V, 2006, BIOCHEM J, V398, P439, DOI 10.1042/BJ20060169
  56. Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
  57. Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175
  58. Pereira RC, 2021, JBMR PLUS, V5, DOI 10.1002/jbm4.10464
  59. Pereira RC, 2019, BONE, V127, P626, DOI 10.1016/j.bone.2019.07.026
  60. Pereira RC, 2015, KIDNEY INT, V87, P593, DOI 10.1038/ki.2014.347
  61. Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008
  62. Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699
  63. Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977
  64. Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071
  65. Simo R, 2012, MOL ENDOCRINOL, V26, P1917, DOI 10.1210/me.2012-1152
  66. SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
  67. Stubbs JR, 2012, J BONE MINER RES, V27, P38, DOI 10.1002/jbmr.516
  68. Suviolahti E, 2006, ANN MED, V38, P337, DOI 10.1080/07853890600865759
  69. Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928
  70. Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
  71. Thakur A, 2019, HEPATOLOGY, V70, P1360, DOI 10.1002/hep.30631
  72. Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815
  73. Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
  74. Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208
  75. Voelkl J, 2021, CLIN SCI, V135, P201, DOI 10.1042/CS20190895
  76. Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823
  77. Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200
  78. Weatherholt AM, 2013, BONE, V52, P372, DOI 10.1016/j.bone.2012.10.026
  79. Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611
  80. Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129
  81. Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172
  82. Yang M, 2013, J CELL SCI, V126, P5692, DOI 10.1242/jcs.135053
  83. Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828
  84. Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871
  85. Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609